Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0000899243-20-035197

Options or other derivatives

  • President and CEO acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
VIRCA NICHOLAS J President and CEO 2020-12-22 Grant or award · Common Stock Option +125,000 125,000 D
Loading xslF345X03/doc4.xml…